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ABSTRACT
ASSOCIATION BETWEEN SERUM FERRITIN AND BODY COMPOSITION IN
YOUNG WOMEN
SEPTEMBER 2009
UJJWALA S DANDEKAR, B.S., SNDT UNIVERSITY, MUMBAI, INDIA
P.G.DIPLOMA, PUNE UNIVERSITY, INDIA
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Alayne Ronnenberg

Iron deficiency is the most common nutrient disorder, affecting nearly two
billion people worldwide. Young, premenopausal women are among those at greatest
risk for iron deficiency. Optimal iron status is critical for work performance, growth,
and maternal and fetal health. The prevalence of obesity is a rapidly increasing in both
industrialized and underdeveloped countries. Previous studies have indicated that excess
adiposity is associated with depleted iron status in adults. Our study explored the dietary
and lifestyle factors associated with measures of iron status in young women. We also
assessed the potential relationship between iron status and adiposity. Data were obtained
from the University of Massachusetts Vitamin D Status Study, a cross-section study of
women aged 18- 30 years. Height and weight were obtained to calculate body mass
index (BMI, kg/m2). Dual x-ray absorptiometry (DXA) was used to measure percent
body fat (%BF). Serum ferritin (SF) and high-sensitivity C reactive protein (hs-CRP)
were measured in fasting blood samples. Dietary intake was estimated using the Willett
semi-quantitative food frequency questionnaire. While total iron intake did not predict
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serum ferritin levels, major contributors of iron intake were cereals, vegetables, lentils
and supplemental iron in the multivariable regression models, which were adjusted for
energy intake. Iron deficiency (SF <12 µg/L) was observed in 28% of the population,
and high %BF (>32%) was found in 45.4% of the population. Although age and hs-CRP
were positively associated with serum ferritin (p <0.01), no association was observed
between serum ferritin and body fat percent (p>0.05). However, hs-CRP was
significantly correlated to BMI and body fat percent (p <0.01). Among the menstrual
characteristics, number of bleeding days was inversely associated with serum ferritin.
Mean serum ferritin was significantly lower in oral contraceptive users than in nonusers
(24.8 (22.8) vs 28.3 (20.5); p<0.05). Our findings suggest that in this population of
young, predominantly normal-weight women, adiposity is not a strong predictor of iron
status. Additional studies are needed to define the relationship between iron status and
adiposity in obese women.
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CHAPTER 1
LITERATURE REVIEW
Introduction
Iron deficiency is one of the most prevalent nutrient disorders. It affects
approximately two billion people worldwide and is the most common cause of anemia
(WHO 2002). Although the prevalence of iron deficiency is greater in developing
nations, it remains a health issue in industrialized countries as well. Because iron plays a
key role in maternal and fetal health, understanding the factors that contribute to iron
deficiency is particularly important in women of reproductive age. According to
NHANES 1999-2000 data, the prevalence of iron deficiency in the United States was
16% and 12%, respectively, in non-pregnant females aged 16-19 and 20-49 years (CDC
2000). Women of child-bearing age are susceptible to iron deficiency due to periodic
menstrual blood loss, and, in pregnant women, the increased iron needs of the fetus.
Maternal iron deficiency is associated with low infant birth weight and preterm delivery
(Scholl and Hediger 1994; Ronnenberg and others, 2004).
The prevalence of obesity in the United States sharply increased from less than
10% in 1990 to 25% in 2007 (CDC 2007). In population studies, increased adiposity
has been found to be a risk factor for iron deficiency (Gillum 2001; Yanoff and others
2007). However, very few studies have investigated this association in young premenopausal women. Therefore, our study assessed the association and predictive value
of body fat, dietary and lifestyle factors on serum ferritin, a biomarker of iron stores, in
a population of 18- to 30-year-old women.
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Functions of iron
Iron is a vital element in all aerobic organisms, and it plays critical functions in
the human body, largely attributable to its oxygen-carrying capacity. The amount of iron
present in a healthy adult is two to four grams. Iron is a binding site for oxygen in hemecontaining proteins, such as hemoglobin in red blood cells and myoglobin in muscle.
Heme consists of a ferrous (Fe2+) iron complex within protoporphyrin IX. (Baynes and
Stipanuk 2000) Porphyrin is a cyclic macromolecule that binds divalent and trivalent
metals like iron to form complexes. Thus, hemoglobin and myoglobin perform the
important function of oxygen transport in human body. (Baynes and Stipanuk 2000)
Iron is a redox (reduction-oxidation reaction) active transition metal that exists
mainly in two oxidative states—ferrous (Fe2+) and ferric (Fe3+). Iron actively
participates in electron transfer chains by reducing ferric iron to ferrous iron and
supplying proton (H+) ions to the cytochromes. Heme, therefore, is an essential
component of cytochrome proteins, which comprise the electron transport chain.
In addition, iron is also an integral part of iron-sulfur (Fe-S) proteins, which are
present in mitochondrial enzymes, thus playing an important role in mitochondrial
single electron transport. These Fe-S proteins, also known as Fe-S clusters, appear in
different forms based on equal number of iron and sulfur ions, with the most common
Fe-S clusters being 2Fe-2S and 4Fe-4S. (Baynes and Stipanuk 2000; Andrews 2000;
Beard 2001)
Iron homeostasis
It is critical to maintain normal levels of iron in the body since iron in excess can
cause toxicity by contributing to free radical production and oxidative stress. As
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mentioned earlier, iron is a transition element that is redox active. When iron is in
excess, it reacts with hydrogen peroxide (H2O2) to produce highly toxic free radicals,
such as superoxide (O2-) and hydroxyl (OH). This reaction, known as the Fenton
reaction, is characterized by reaction of ferrous (Fe2+) iron with hydrogen peroxide
(H2O2), producing ferric (Fe3+) iron and a hydroxyl radical. This toxicity can cause cell
injury, such as DNA damage, lipid peroxidation and oxidative damage to proteins.
(Valko, Morris, Cronin 2005)
Maintaining whole-body iron homeostasis is an important and dynamic process
involving several mechanisms, including regulation of intestinal iron uptake, cellular
availability, storage and transport through various proteins.

Regulation of iron availability
Iron availability is tightly regulated by an array of proteins, including transferrin
(Tf) and ferritin, which are responsible for iron transport and storage, respectively.
These proteins bind iron in the ferric (Fe3+) form, which is non-reactive. This helps
inhibit the reaction of free iron with oxygen, which can lead to free radical formation
and cell injury.
Iron availability in the body is regulated through intestinal absorption, posttranslational
regulatory mechanisms, recycling of iron in macrophages and cellular storage of iron.
Iron absorption is regulated by transport of iron through the small intestine,
which depends on the rate of erythropoiesis and the reduction in body iron stores.
Erythropoeisis takes place in bone marrow. The ferrous iron absorbed from the diet and
transported by the plasma protein transferrin, as well as iron recycled by

3

reticuloendothelial macrophages, is taken up by the bone marrow erythroblasts. Excess
iron is stored in the form of ferritin. Iron is stored primarily in hepatocytes.
Erythropoiesis continues to use this stored iron in case of reduced supply or loss of iron.
(Andrews 2000)

Intestinal absorption of non-heme iron
Dietary non-heme iron is absorbed in the proximal duodenum of small intestine.
A protein known as divalent metal transporter- 1 (DMT-1), present on the brush border
membrane of the enterocyte, is responsible for the uptake of non-heme iron. The nonheme iron is in the ferric (Fe3+) form, which is insoluble. It is reduced by an unidentified
ferrireductase along with duodenal cytochrome b (Dcytb). The exact ferrireductase has
not been identified yet, since Dcytb was not found to be entirely responsible for
reducing ferric iron at the brush border membrane (Gunshin and others 2005). The
ferrous (Fe2+) iron is then transported by DMT-1 into the enterocyte. It is a proton (H+)
coupled transport process, which takes place at a low pH (Gunshin and others 1997).
Iron is exported from the enterocyte to the circulation by a protein named ferroportin
(Fpn), situated at the basolateral membrane. Likewise, Fpn is also located at the
macrophage membrane, where it exports recycled iron harvested from senescent RBCs
(Hentze, Muckenthaler, Andrews 2004). The ferrous iron thus exported from the
enterocyte is then oxidized by ferroxidase, called hephaestin, in the interstitial space to
the ferric form again. Thus, ferric iron bound to transferrin enters the circulation or is
stored as ferritin (Andrews 2008). The diferric transferrin is utilized further for
erythropoiesis and storage. Depletion of iron stores in the form of ferritin triggers
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upregulation of DMT1, which results in enhanced intestinal uptake of iron (Gunshin and
others 1997).

Figure 1: Intestinal non-heme iron absorption
(Source: Gunshin H)

The transferrin cycle
Transferrin is a plasma protein secreted primarily by hepatocytes. Tf is an iron transport
protein whose key role is the formation of RBCs, called erythropoiesis.

Figure 2: The transferrin cycle: Receptor mediated endocytosis
(Source: Gunshin H)
5

Tf binds iron and transports it to the cells for further use. It has two binding sites for
ferric (Fe3+) iron. For cellular uptake, iron is internalized with transferrin (Tf) receptors
(TfR) in the diferric form. The process through which iron is internalized into the
endosome of red blood cells is known as endocytosis. The Tf-Fe3+ complex binds to the
transferrin receptor (TfR1) present on the cell surface. This complex is then internalized
through clathrin-coated pits, which are vesicles for endocytosis. The bound iron is then
released within the endosomes due to their acidification by a proton pump. Ferric iron
released from the Tf-TfR1 complex is reduced to ferrous iron. DMT-1 then transports
Fe2+ from the endosomal membrane into the cytoplasm to be further used by
mitochondria or stored in the form of ferritin. Iron is stored mainly in
reticuloendothelial macrophages and hepatocytes. These iron stores are then utilized
during reduced supply or deficiency (Hentze, Muckenthaler, Andrews 2004).

Post transcriptional regulation of iron
Cellular iron balance is maintained at a post-transcriptional level by iron
regulatory proteins that bind with RNAs. Iron regulatory proteins (IRP) contain a ironsulfur complex and are an isoform of cytosolic aconitase. When cellular iron stores are
replete, IRP is iron saturated and actively binds RNA. In case of iron deficiency,
however, the iron-sulfur cluster in IRP becomes unstable and, consequently, binds to
iron responsive elements (IRE). IREs are stem-loop structures that are present in 5’ or 3’
untranslated regions (UTR) of mRNAs.
Therefore, when the cellular iron pool is depleted, IRP binds to the 5’ UTR of
ferritin mRNA, thus preventing the biosynthesis of ferritin. As a result, iron is not stored
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during iron deficiency. Simultaneously, when IRP binds to the 3’ UTR of the transferrin
receptor mRNA, it results in the stabilization of mRNA. Thus, mRNA is intact for a
longer period of time to trigger synthesis of TfR, thus elevate the uptake of iron by cells.
Both ferritin and TfR levels in the serum are important indicators of iron status: low
ferritin and high TfR concentrations are biomarkers of iron deficiency (Baynes and
Stipanuk 2000).
Recycling of iron
Recycling of iron takes place in macrophages of the reticuloendothelial system,
which take up old RBCs by phagocytosis. Iron from hemoglobin is then recycled and
transported across the macrophage membrane by Fpn to the circulation and to the liver
for storage. (Andrews 2000)

Figure 3: Recycling of iron in macrophages
(Source: Gunshin H)
Proteins in iron metabolism
Ferritin
Ferritin is an iron storage protein characterized by 24 subunits. These subunits
are comprised of heavy (H) and light (L) chains, which form a hollow apoferritin shell
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and hold nearly 4500 atoms of iron. Apoferritin binds iron in its ferrous (Fe2+) form and
then oxidizes it to ferric (Fe3+) iron. In this form iron is non-reactive and thus, non-toxic
to the cells. The H subunit of ferritin has ferroxidase activity, which is an essential
characteristic of this iron storage protein. The heavy subunit is found mainly in heart
tissue, and the light subunit is found in liver cells. (Macara, Hoy, Harrison 1973)
Once iron is absorbed in the duodenum, it is transported across the enterocyte
and is either transported to cells in the transferrin-bound form, or the surplus iron is
stored in the form of ferritin. When iron is required for erythropoiesis, it is released
from ferritin. Thus, ferritin levels can reflect an early stage of iron deficiency in a
normal healthy adult and are considered a sensitive biomarker of iron deficiency.
However, chronic inflammatory conditions can alter serum ferritin levels, resulting in a
false estimation of iron stores. This can be explained by alterations in ferritin due to the
inflammatory response.
Ferritin is a positive acute-phase protein, which means that its levels rise in
response to inflammation. Stimulation of interleukins such as IL-1 and IL-6 gives rise to
increased transcription of ferritin. Thus, chronic inflammatory conditions cause
increased serum ferritin levels. Inflammatory cytokines can also cause downregulation
of Fpn, which results in sequestration of iron in the macrophages (Weiss and
Goodnough 2005). Therefore, in inflammatory conditions or chronic disease, serum
ferritin can be elevated and might not serve as an appropriate measure of iron status.
Hephaestin
Hephaestin is a ferroxidase located at the basolateral membrane of enterocytes. It
facilitates the conversion of ferrous iron (Fe2+) to ferric iron (Fe3+), thus being
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responsible for iron export from the intestinal cell to the circulation. It is a copper
dependent protein and is homologous to ceruloplasmin. The Tf-bound ferric iron then
enters the circulation. (Andrews 2000)

Figure 4: Iron storage and transport proteins
(Source: Andrews NC 2000)

Hepcidin
Hepcidin is a peptide hormone which is synthesized by the hepatocytes. It is
homologous to anti-microbial defensin peptide present in the human immune system,
which explains its potential role in inflammation and defense system (Park and others
2001). Hepcidin appears to be instrumental in iron metabolism, regulating the export of
absorbed intestinal iron. This mechanism can be explained by the binding of hepcidin
with ferroportin (Fpn) (Nemeth and others 2004c; Nemeth and others 2004b). As
mentioned earlier, Fpn is an iron-transport protein primarily located at the basolateral
membrane of intestinal cells as well as macrophages. Hepcidin binds with Fpn at the
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membrane, and this complex is then internalized and degraded by lysosomal enzymes.
As a result, Fpn degradation inhibits iron export from the intestinal cells. The same
mechanism takes place in the macrophage, where the release of iron recovered from
senescent RBCs is inhibited. Hepcidin release from the liver is controlled by the
erythropoietic need and body iron stores. In iron deficiency, hepcidin is downregulated,
thus enhancing iron efflux by Fpn into the circulation. When serum iron levels are
normal, Fpn is reduced following increased degradation caused by binding of hepcidin,
thus inhibiting excess iron export into plasma (Nemeth and others 2004b).
Interestingly, the hepcidin mechanism in inflammatory conditions has been a key
component in understanding the physiology underlying inflammation and poor iron
status.
Chronic diseases, bacterial and viral infections and autoimmune diseases trigger
immune responses by production of cytokines such as interleukin-1, interleukin-6,
interleukin-10, TNF-α, interferon-γ. These cytokines cause different responses by iron
regulatory proteins. For instance, hepcidin is up-regulated as a defense system in
response to inflammation. Elevated hepcidin levels, through the down-regulation of
Fpn, cause iron to be sequestered in enterocytes and macrophages, which inhibits iron
release into the plasma. This results in reduced plasma iron levels, reduced
erythropoiesis, and consequently anemia.
Hepcidin is an acute phase reactant and its synthesis is triggered by IL-6 more
than by IL-1α and TNF-α. Ferritin is synthesized in response to IL-1 α and TNF- α
(Nemeth and others 2003; Nemeth and others 2004b). Recently, hepcidin expression
was studied in chronically obese subjects. Adipocytes from these subjects showed
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increased expression of hepcidin mRNA, which could lead to iron sequestration in
enterocytes and macrophages (Bekri and others 2006). In another study, serum hepcidin
was negatively associated with iron absorption in healthy young women (Young and
others 2009). This observation suggests that hepcidin is important in understanding iron
status in obese and non-obese persons.

Iron deficiency
Iron deficiency (ID) corresponds to the depletion of a functional iron pool in
different tissues to a sufficient degree so as to impair optimal function. Iron depletion in
the body occurs in stages and can be measured by utilizing a battery of biomarkers of
iron status. The total body iron content in a normal healthy adult is approximately 3.54.5 g/kg body weight (Andrews 1999). Most of this iron is utilized and recycled by the
circulating erythrocytes in the form of hemoglobin. The amount of iron taken up by
immature RBCs for hemoglobin synthesis can account for up to 2.8 gm/kg body weight
and 3.2 gm/kg body weight in women and men, respectively, and is delivered to these
cells by the iron transport protein transferrin. About 0.6 gm of iron is utilized by
myoglobin, transferrin and cytochromes. Any surplus body iron is stored in the cells in
the form of ferritin and hemosiderin (Baynes and Stipanuk 2000). Measurement of
ferritin in plasma is a good indicator of body iron stores. When insufficient iron is
available for hemoglobin synthesis, typical signs of iron deficiency anemia develop,
including low blood hemoglobin and hematocrit and red blood cell microcytosis.
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Etiology of iron deficiency and iron deficiency anemia
Iron deficiency is the primary cause of anemia worldwide. Poor iron intake,
inadequate bioavailable iron, blood loss due to menstruation and mucosal blood loss
through intestinal cells are potential conditions that lead to iron depletion (Cook and
Skikne 1989; Finch and Cook 1984). Although there is no defined pathway for iron
excretion, under normal condition about 1-2 mg of iron is typically lost from the body
each day, primarily through occult blood loss into the intestine. This obligatory iron loss
needs to be replaced through dietary iron absorption (Andrews 2000).
A higher prevalence of iron deficiency anemia is commonly found in women
than in men in industrialized as well as developing nations (Finch and Cook 1984).
Menstrual loss and pregnancy are the principal reasons for iron deficiency in women of
child-bearing age. Menstrual blood losses average up to 40-50 mL, thus accounting for a
loss of nearly 24 mg of iron each month, which explains the increased iron requirements
in this group of women (Hallberg and others 1966). The RDA for women aged between
19-50 years is 18 mg, which is more than twice as great as that of males (8mg).
Optimal iron status during pregnancy is critical for maternal and fetal health.
The expansion of plasma volume and fetal iron demand during pregnancy increases the
RDA for iron in pregnancy up to 27 mg. (Baynes and Stipanuk 2000). Prenatal iron
deficiency and iron deficiency anemia are associated with a doubling of the risk of
preterm delivery and low infant birth weight (Scholl and Hediger 1994). Maintaining
optimal iron status is essential even at the preconception stage. Iron deficiency anemia
at this stage can result in abnormal pregnancy outcomes. A study in young Chinese
women showed that poor iron status prior to pregnancy increased the risk of infant low
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birth weight and growth restriction (Ronnenberg and others 2004). These data
underscore the need to evaluate factors associated with the development of iron
deficiency in pre-menopausal women.
Stages of ID can be explained by successive depletion of iron from storage
tissues to transport proteins, and finally manifesting as iron deficiency anemia (IDA).
1. Iron depletion: Iron depletion starts from the storage site (ferritin in the bone
marrow). At this stage, serum ferritin is the most sensitive indicator of body iron stores.
2. Iron deficient erythropoiesis: Depletion of iron stores in the bone marrow results in
reduced iron for erythroblasts, known as iron-deficient erythropoiesis. As a response to
the reduction in iron stores, iron absorption and transport are enhanced by means of up
regulation of proteins such as DMT-1, transferrin (Tf) and transferrin receptors (TfR).
Therefore, iron depletion at this stage can be examined by a number of parameters such
as mean cell volume (MCV), % transferrin saturation (TS), and free erythrocyte
porphyrin (FEP) (Cook and Skikne 1989; Finch and Cook 1984).
3. Iron deficiency anemia: The last stage of iron depletion is iron deficiency anemia
(IDA). This can be assessed clinically by hemoglobin (Hb) content as well as serum
transferrin receptor and ferritin (Cook, Skikne, Baynes 1993).

Biomarkers of iron status
Iron status may be assessed in various ways. The sensitivity and specificity of
these parameters have been studied to identify the most accurate and reliable biomarkers
of iron status. If iron depletion is diagnosed at an early stage, preventive measures of
iron supplementation can be implemented to improve iron status.
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Bone marrow examination
Iron from the storage site is taken up by the erythroblasts present in bone
marrow. Bone marrow examination includes histological assessment of iron stores.
Although it is considered the most definitive measurement of iron status, it is not used
for screening of iron deficiency in major populations because of its invasiveness. It is
mainly used to assess iron status in hospitalized patients. (Cook and Skikne 1989)
Hemoglobin
Hemoglobin is iron bound to a protein in circulating erythrocytes. Hb is used for
screening of anemia in large populations. However, it is not a reliable measure because
there are different types of nutritional anemia which can result into false estimation of
iron deficiency. The normal Hb levels can vary according to different populations as
well as age, sex and hydration status. However, the cut-off level as per WHO standard is
13g/dL for adult men, 12g/dL for non-pregnant women and 11g/dl for pregnant women
(Cook and Skikne 1989).
Free erythrocyte protoporphyrin (FEP)
The heme molecule consists of protoporphyrin IX and iron. In the later stages of
iron deficiency, free erythrocyte protoporphyrin levels increase as a manifestation of
reduced heme synthesis. This is not the most sensitive indicator of iron deficiency, since
it is a late stage of iron depletion leading to iron-deficient erythropoiesis. The cut-off
value for FEP is 70µg/dL. Increased levels of FEP indicate iron deficiency anemia.
(Cook and Skikne 1989)
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Mean cell volume (MCV)
MCV is not sensitive to depletion of iron stores, but iron deficient erythropoiesis
and iron deficiency anemia are associated with microcytosis (small cell volume), so
MCV measurements are useful in determining the type of anemia. However, MCV can
also decrease in infection or chronic disease, leading to a false assessment of iron
deficiency anemia. Therefore, MCV alone is not considered a reliable measure of iron
deficiency. The normal value for MCV is 80 fL. (Cook and Skikne 1989)
Transferrin saturation
Transferrin saturation measures how much iron is bound to transferrin and is
expressed in the form of “% saturation”. Transferrin saturation <16% reflects iron
deficiency. Similar to other iron-related measures, such as Hb, MCV and FEP,
transferrin saturation measurements are not sensitive to early stage depletion of iron
body stores. Also, it can also be a false indicator of iron deficiency, since it can vary in
case of clinical disorders. (Cook and Skikne 1989)
Serum ferritin
Iron is stored in the body in the form of ferritin. Using quantitative phlebotomy
experiments in normal subjects, serum ferritin concentration was shown to reflect body
iron stores in normal individuals, as well as in persons with iron deficiency or iron
overload disorders; 1 ng/ml of serum ferritin reflects 8 mg of body iron stores (Walters,
Miller, Worwood 1973). In case of dietary iron deficiency, iron stores are utilized to
supply iron metabolic needs. Therefore, low serum ferritin concentrations reflect
depleted body iron stores. In case of iron overload disorders, serum ferritin
concentration is elevated above normal. Measurement of serum ferritin is the most
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sensitive indicator of body iron stores in a normal healthy adult. Although cut-off values
for serum ferritin have been defined by different population groups, the normal range of
serum ferritin falls within 20-200 µg/L, with <12 µg/L indicative of depleted iron stores.
(Baynes and Stipanuk 2000; Hallberg and others 1993)
However, because ferritin protein is an acute-phase reactant that increases in
response to inflammation or chronic disease, serum ferritin concentration can lead to a
false indication of the extent of body iron stores in persons with concomitant infection
or inflammation. (Punnonen, Irjala, Rajamaki 1997)
Serum transferrin receptor
A soluble truncated form of the transferrin receptor (TfR) can be detected in
serum samples. The circulating transferrin receptor assay was first designed by Yutaka
Kohgo et al.(1987). Iron deficiency gives rise to up regulation of cell surface expression
of transferrin receptors that are reflected in an increase concentration of circulating
soluble transferrin receptors (Kohgo and others 1987; Cook, Skikne, Baynes 1993).
Similar to ferritin, the synthesis of TfR is also controlled by a post-transcriptional
mechanism. When free iron is low in the cytoplasm, as in iron depletion, TfR synthesis
is up regulated as a result of IRP binding with TfR mRNA.
Because ferritin is an acute-phase reactant, its usability is compromised to some
extent in cases of inflammation, liver disease and chronic disease. To distinguish iron
deficiency anemia from the anemia of chronic disease (ACD), serum TfR measurements
are a helpful indicator of iron deficiency, since its concentration is stable in
inflammatory conditions (Cook, Skikne, Baynes 1993). However, when used alone,
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serum TfR gives no information about body iron stores, and it is also affected by other
conditions that influence the rate of erythropoiesis.
Recently, some studies have used the ratio of soluble TfR to serum ferritin to
distinguish iron deficiency anemia from anemia of inflammation. The index of sTfRlog ferritin has been found to be useful in assessment of body iron stores. (Punnonen,
Irjala, Rajamaki 1997)

Dietary factors affecting iron status
Iron intake
Heme and non-heme iron are two forms of iron available from animal and plant
foods. Heme iron is derived from hemoglobin and myoglobin present in animal tissues,
such as meat, seafood and poultry. Nonheme iron is also found in animal sources,
including egg yolk and milk, as well as in plant sources, including fortified grains and
cereals, leafy green vegetables, nuts, oilseeds and legumes (Baynes and Stipanuk 2000).
A study by Hunt et al (1999) assessed non-heme iron absorption from a
lactovegetarian diet compared to heme iron absorption. The bioavailability of heme iron
(3.8%) was found to be 70% higher than that of nonheme iron (1.1%). (Hunt and
Roughead 1999) This greater bioavailability is likely related to the structure of heme
(Hb)3, which facilitates absorption and is unaffected by dietary inhibiting factors that
influence absorption of nonheme iron. (Pizarro and others 2003) These studies indicate
that heme iron intake enhances the bioavailability of iron. While this suggests that
greater heme iron intake should improve iron status, recent studies have shown that
dietary intake of heme and non-heme iron were not associated with iron status (Asakura
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and others 2009; Pynaert and others 2007; Yanoff and others 2007). These observations
suggest that, along with dietary iron intake, other nutritional and non-nutritional factors
also influence iron absorption and iron status.
Absorption of nonheme iron
Nonheme iron absorption is a complex process that involves a number of other
nutrients and dietary components that can be broadly classified as enhancers of or
inhibitors of iron absorption.
Enhancers of non-heme iron absorption
Ascorbic acid
The availability of the dietary iron can be enhanced by consumption of ascorbic
acid. In previous studies, radioactive iron administered with vitamin C in single meal
showed enhanced iron absorption as compared to the long term supplementation of
vitamin C. One such study by Cook et al (2001) showed a positive correlation between
log of iron absorption and log of vitamin C consumption. (Cook and Reddy 2001)
Vitamin C is thought to enhance iron bioavailability by reducing insoluble ferric iron
into ferrous form, which leads to increased absorption.
Meat Factor
The bioavailability of non-heme iron can be enhanced by addition of meat to the
meal. This was tested in Latin-American basal meal, to which 75 g of ground beef meat
was added, nearly tripling non-heme absorption from 0.17mg to 0.45 mg (Hallberg and
Rossander 1984). Although the factors underlying this enhancing effect have not been
identified yet, some studies have concluded that isolated protein extracts from muscle
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proteins present in chicken and beef enhance non-heme iron absorption by 100% and
180%, respectively (Hurrell and others 2006).
Vitamin A
Vitamin A is essential for vision, immunity, cellular differentiation and
hematopoiesis. In addition, vitamin A supplementation improves iron status in many
epidemiologic studies. A cross-sectional study in 1060 Thai children aged 1-8 years,
which continued later with vitamin A intervention trial, indicated a positive association
of retinol with iron status indices. In the intervention trial, vitamin A supplementation
improved iron status significantly (Bloem and others 1989). Another study, conducted
in 100 Venezuelan subjects, reported a significant increase in non-heme iron uptake
when supplemented with varying concentrations of vitamin A and β-carotene. The
meals were composed of rice, wheat and corn. Vitamin A and β-carotene improved the
absorption of iron 0.8-, 1.4- and 2-fold for wheat, corn and rice, respectively. The
researchers suggested that vitamin A might have a binding effect on iron that makes it
soluble and more bioavailable. Others have suggested that vitamin A could be
responsible for mobilizing iron from ferritin stores to the circulation, thus enhancing
erythropoiesis (Garcia-Casal and others 1998).
Copper
Copper deficiency and its relation to iron deficiency have been studied to a large
extent. In-vivo studies have shown that copper deficiency causes a significant reduction
in iron absorption to about 50% (Reeves and DeMars 2004). The possible underlying
mechanism corresponds to altered function of a ferroxidase called hephaestin situated at
the basolateral membrane of the intestinal cell. Hephaestin is responsible for oxidation
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of Fe2+ to Fe3+, the latter is then transported into the blood stream. This ferroxidase is
copper dependent, which justifies the mechanism of copper deficiency resulting in iron
deficiency by restricting the passage of iron from enterocyte to the blood stream, thus
leading to reduced serum iron. Deficiency can also adversely affect ceruloplasmin (Cp),
which is a copper containing enzyme present in circulation. In other words, it is another
form of ferroxidase responsible for iron transport (Reeves and DeMars 2004).

Inhibitors of iron absorption
Phytates
Whole grains such as wheat, oats and rye that are not extensively processed have
higher bran content. The bran or husk contains high amounts of phytates, which are also
known as inositol phosphates. Cereal grains that are rich in phyates hinder iron
absorption. A study by Mats Brune et al (1992) assessed the effect of phytates with
different formulations of bread with combinations of different flours, and number of
phosphates. The study showed that the higher the number of phosphates in inositol, the
greater the inhibitory effect. Inositol phosphate is commonly seen in hexaphosphate or
pentaphosphate form. Cooking methods such as fermentation and acidic media can
reduce the number of phytates, thus attenuating its hindering effect to some extent.
Fermentation breaks down phosphates to inorganic phosphates and reduces the number
of phosphates, thus minimizing its effects. Also, the addition of lactic acid might
decrease the phytate content in grains (Brune and others 1992).
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Polyphenols
Polyphenols are ring structures that contain more than one hydroxyl group. They
are commonly found as tannic acid, gallic acid present in tea, coffee, red wine, spinach
and spices such as cinnamon. These hydroxyl groups bind iron and make it unavailable
for absorption (Zijp, Korver, Tijburg 2000). The inhibitory effect of these polyphenols
on iron absorption has been widely studied. One such study performed by Layrisse M et
al examined iron absorption from controlled breakfast meals that included specific
doses of tea and coffee. The results showed that a dose-dependent administration of tea
and espresso coffee indicated a 50% decrease in iron absorption (Layrisse and others
2000). This suggests that the consumption of tea and coffee is one of the important
determinants of iron absorption.
Calcium
Calcium is critical for bone health. Although calcium supplementation may be
beneficial for maintaining women’s bone health, it might also hinder iron absorption.
Cook et al (1991) determined the effect of different calcium supplements on absorption
of dietary labeled non-heme iron and supplemental iron in 61 subjects (28 women and
33 men). When supplements containing both calcium carbonate and iron were taken
without food, iron absorption was reduced by 15% (P= 0.10) as compared to 24% when
taken with meal. (p=0.01). However, when the supplement was taken along with food
with more bioavailable iron and low in calcium content, iron absorption was reduced up
to 28% as against 55% reduced absorption in a meal with less bioavailable iron and high
calcium content. (Cook, Dassenko, Whittaker 1991). Based on this study, it is evident
that calcium has a potential inhibitory effect when consumed with meals.
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Non-nutritional factors affecting iron status
Blood loss
Other than dietary deficiency, blood loss is one of the main factors that leads to
iron depletion. Blood loss in terms of mucosal loss from the intestine, menstrual blood
loss and blood donation can lead to depletion of iron stores and iron deficiency. A
Danish study in women of childbearing age evaluated serum ferritin levels of
menstruating as well as menopausal blood donors. The results indicated that serum
ferritin levels for multiple time blood donors were significantly less than one-time
donors, 19 µg/L versus 24 µg/L, respectively. Reduced serum ferritin levels were a
result of frequency of blood donations as compared to number of donations. With the
greatest frequency of four blood donations a year, serum ferritin levels were recorded as
low as 16µg/L in menstruating women (Milman, Sondergaard, Sorensen 1985). Thus,
frequency of blood donations can potentially modulate serum ferritin levels.
The amount of menstrual blood loss is an important cause of iron loss in
premenopausal women. The number of days in a menstrual period and the rate of blood
loss determine iron stores. According to a study conducted by Milman N et al, serum
ferritin concentration in premenopausal women was significantly lower than in postmenopausal women, and 17% of the former had iron depleted stores, defined by serum
ferritin <15µg/L. This was also supported by a more detailed study by a group in
Finland (Fogelholm and others 1993) that observed that lower serum ferritin and Hb
were associated with more frequent and longer menstrual periods.
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Use of contraceptives
In a report by the CDC (2002), it was reported that in the age group of 15-44
years, oral contraception was the preferred method (31%: 11.6 million) of contraception,
followed by female sterilization (27%: 10.3 million), which was preferred by women
over 35 years. The use of IUD is less than 3% in United States. (CDC 2002)
The inter-relationship of use of Intra Uterine Device (IUD), oral contraceptives
and iron status has been studied by various groups. Studies conducted in Swedish
women showed that after the insertion of the IUD, increased menstrual blood loss was
observed, but there was no considerable alteration of iron status (Larsson and others
1993). However, a study in Finland observed a reduction in Hb and serum ferritin levels
after insertion of copper IUD devices (Fogelholm and others 1993). Iron depletion is a
result of many factors, so population differences may modulate the prevalence of this
condition. For example, since IUD use is not very common in young population in
United States, it is less likely to alter iron status in college–aged women in this country.
On the other hand, oral contraception is likely to have a more important
contribution to iron status due to its widespread use in this age group. The effect of oral
contraceptives on iron status depends on the formulation of the pill. Oral contraceptive
pills are primarily composed of synthetic estrogen and progestin hormones, which
control the release of follicle stimulating hormone (FSH) and leutinizing hormone (LH).
These hormones facilitate maturation and release of an ovum from the ovaries. The
synthesis of FSH and LH is inhibited by oral contraceptives. Thus, the principal
mechanism of action of contraceptives is to prevent ovulation. Progestin also thickens
the cervical mucus, thus preventing fertilization of the egg by sperm. This could result
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in reduced endometrial proliferation and lighter menstrual flow (Burkman 2001;
Casabellata and others 2007) and lower iron loss. A study by Frassinelli-Gunderson EP
et al (1985) assessed the impact of oral contraceptives (OCs) on iron status parameters
and found significant improvement in serum ferritin, TIBC, serum transferrin, MCV and
serum iron (Frassinelli-Gunderson, Margen, Brown 1985). Milman N et al (1985) also
reported that serum ferritin concentration was increased in women who used OCs
(Milman, Sondergaard, Sorensen 1985).
On the other hand, the use of low-dose oral contraceptives might not
significantly improve iron status. Larsson et al (1992) studied the effect of low dose
OCs in 20 young women, and found that serum ferritin status did not change
significantly after six months. The principal reason behind these contradictory findings
might be the composition of OCs. Previously, OCs were composed of high-dose of
estrogen and progestogen, as compared to the current low-dose products. The former
OCs reduced the menstrual blood loss more than the low hormone formulas, thus
resulting in improved iron status due to the higher administered hormone dose (Larsson
and others 1992).

Epidemiology of iron status and body composition
Obesity has been linked to many chronic disorders such as diabetes,
cardiovascular disease, and ischemic heart disease (Hubert and others 1983). Body
composition measures, such as body mass index (BMI), percent body fat, and lean body
mass, are useful measures of body composition. Several recent epidemiologic studies
have described the association between iron status and measures of body composition
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and found a significant association between iron status and body fat in children and
adults.
In the Third National Health and Nutrition Examination Survey (NHANES III),
the association between serum ferritin and adiposity was studied. Adiposity
measurements included waist-to-hip ratio (WHR), BMI, waist-to-thigh ratio (WTR),
and a combination of skinfold ratios. The study population was Mexican-American men
(n=1416) 20-49 years of age. This population was selected considering the high
prevalence of obesity observed in Mexican Americans and to eliminate potential
confounding factors observed in females, such as menstruation, pregnancy, menopause
and hormonal treatments. The study reported a positive correlation between serum
ferritin with increased age, particularly when the 25-29 y age group was compared to the
older age groups. WHR, BMI and other measured indices increased with increasing age.
Serum ferritin was positively correlated with WHR, a moderately strong correlation
(r=0.36) being found in age of 20-24 years. Other parameters such as BMI (r=0.34),
waist circumference (r=0.34) and sum of skinfolds (r=0.32) positively correlated with
serum ferritin in all age groups, with the age group of 20-24 years being the highest. In a
linear regression model, these associations remained statistically significant (P = 0.001)
for the age subgroup of 20-29 years (Gillum 2001).
One of the limitations of this study was that the accuracy of body fat mass
estimations. Although anthropometrics have been used conventionally for obesity
screening, DEXA (Dual Energy X-ray Absorptiometry) measurement is more accurate
measure of body fat mass, fat distribution and lean body mass (Mazess and others
1990). Also, because this study was limited to Mexican-Americans, its findings may not
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be generalizable to other groups. This study also did not assess the relationship in young
premenopausal women, where a variety of factors, such as oral contraceptive use,
menstrual loss and pregnancy, other than adiposity might alter iron status.
Two more studies that have observed this association studied an adult population
whose mean age was approximately 50 years. A New York City-based cohort included
a racially diverse population (n=670; mean age 54+ 17years) comprised of males and
females. DEXA, which is a gold standard for body composition measures, was used to
assess body fat along with traditional methods, such as BMI and waist circumference.
The overweight and obesity prevalence in the whole group was 60%, with similar BMIs
for males and females (26.87+5.16). When studied based on gender and DEXA
measures, females had a significantly higher percent body fat (37.8%) than males
(24%). Similarly, fat mass was also greater in females (26.8 kg) than males (19.4 kg).
The researchers (Chambers and others 2006) reported a negative correlation between
serum iron and body fat measures such as BMI (r= -0.23, P<0.001), waist circumference
and fat mass (r= -0.19, P < 0.05), although the correlation was significant only in the
group of Hispanic women (Chambers and others 2006).
As mentioned previously, serum ferritin is the most sensitive indicator of body
iron stores (Cook and Skikne 1989). Therefore, it might have been more appropriate to
use a combination of iron status indicators. Since the population was mostly adult (mean
= 54 years), it might have included a large portion of postmenopausal women, which
could have potentially altered iron status. Also, the results of this study were limited for
Hispanic women, who have a greater prevalence of obesity and consequential iron
deficiency. So, this may not represent what will be observed in all population groups.
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Due to the limited information on the menstrual status, this effect could not be
measured. This study also did not include other essential factors, such as dietary intake
data, use of supplements, socio-economic status and activity level, that could influence
iron status. Since these factors play vital roles in predicting iron status, and it is
important to have complete data when assessing the iron status of populations. Thus
selection of appropriate measurement parameters of fat mass as well as functional and
storage iron is important to evaluate an interrelationship between the two factors.
A recent study by Yanoff et al (2007) explored the possible reasons for the low
serum iron levels (hypoferremia) observed in obesity. It was a comprehensive study that
involved a wide range of iron status measurements, 7 day dietary intake records, an
extensive questionnaire and various body fat indices including DEXA. This study
involved a convenience sample of 234 obese and 172 non-obese subjects who were men
and women of age 18-70 years from the Washington DC metro area. Excluded from the
study were subjects with chronic and inflammatory diseases, which tend to alter iron
levels. For body fat mass assessment, DEXA scans were performed following a 10-hour
overnight fast. Iron status was assessed by measuring serum iron, serum ferritin, Hb,
MCV, transferrin saturation and serum transferrin receptor. Although the study
population aged ranged between 18-70 years, the mean age was in late 30s
(approximately 38 years). Like other studies (Chambers and others 2006; Gillum 2001),
this study also reported negative associations between serum iron and BMI and serum
iron and fat mass (P= 0.0003) in univariate as well as in multivariate linear regression..
Transferrin saturation and MCV were also inversely associated with fat mass. (P <0.05)
As expected, serum transferrin receptor and C-reactive protein (CRP; a marker of
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inflammation) were positively correlated with the body fat measures. (P< 0.05) In
multivariate analysis, serum ferritin was positively correlated with BMI and fat mass.
(P<0.05) Dietary iron intake was not significantly associated with serum iron. Elevated
serum transferrin receptor, a biomarker of iron deficiency, was significantly more
common in obese (26.9%) than in the non-obese group (15.7%). Based on
socioeconomic levels, the proportion of whites in this study was higher in the nonobese/healthy group as compared to the obese group, which had high proportion of
African Americans. (Yanoff and others 2007)
Although this study showed an inverse association between iron status and
adiposity, it did not explore these relationships specifically in 18- to 30-year-olds. A
significant relationship between body composition and iron status has also been
observed in developing countries. An inverse association between body iron and BMI
was seen in Moroccan and Indian children (p <0.0001). BMI Z-score was positively
associated with serum ferritin (p =0.021), and transferrin receptor and zinc
protoporphyrin (ZPP) (p<0.0001), and was negatively associated with estimates of body
iron (ratio of serum ferritin/ transferrin receptor). In the same study, an iron
intervention trial (~4mg labeled iron fortification meal) in Thai women (19-50 years)
reported association of decreased iron absorption and compromised iron status at a
higher BMI (P = 0.030; P< 0.001, respectively). The change in body iron and serum
ferritin in response to iron supplementation was negatively associated with a higher
BMI in children (p<0.0001). (Zimmermann and others 2008)
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Physiological evidence of serum hepcidin mechanism
Although the biological mechanism behind iron deficiency and obesity is not
clear, some mechanisms have been hypothesized. Stimuli by inflammatory adipokines
such as IL-6 and TNF-α can up regulate hepcidin synthesis as well as sequester iron at
storage sites. (Nemeth and others 2004a; Trayhurn and Wood 2004) To examine the
physiological relationship underlying the association between adiposity and iron
depletion, hepcidin expression was observed in hepatocytes and adipocytes of critically
obese subjects. Hepcidin expression in adipose tissue was associated with IL-6 and CRP
and 68% of the obese subjects were found to have low transferrin saturation and anemia
was reported in 24% of obese population. (Bekri and others 2006) This study supports
the idea that excess obesity is associated with hepcidin-mediated iron deficiency.
To explore this association further, the effect of hepcidin on iron absorption was
studied in young healthy women. Isotopic iron in the form of ferrous sulphate was
administered to 18 young women, with and without a non-heme food source (sweet
potato~ 1.4 mg Fe), followed by standardized meals. The experiment was repeated the
next day and the iron absorption under the two conditions was assessed. Serum hepcidin
levels were also analyzed and were found to be inversely associated with iron absorption
both with and without food (p= 0.038; p= 0.0296 respectively). (Young and others
2009)
Other proposed mechanisms behind the inverse relationship between iron status
and body fat include poor dietary intake of iron and increased requirement of iron
attributed to larger blood volume. However, these two mechanisms have not been
sufficiently tested yet. ((Menzie and others 2008; Yanoff and others 2007)
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To summarize, there has been substantial evidence suggestive of an association
of iron status with measures of body fat mass. However, very few studies have tried to
determine this association in healthy young women. One such recent study by Karl et al
(2009) attempted to examine the association of iron deficiency with BMI and body fat in
young women who were military recruits. Among 207 women aged 18 to 41 years that
were studied, 36.8% were iron deficient. However, iron deficiency (defined as: red cell
distribution width > 15.0%, transferrin saturation < 16.0%, serum ferritin < 12.0 ng/mL)
was not significantly different in groups of normal and overweight subjects. Moreover,
BMI (25-30 kg/m2) and body fat (> 30% via skinfolds) were not significant predictors of
iron status in this group of young women. Stratified analysis of body fat and BMI also
did not indicate a significant risk of iron deficiency associated with adiposity. The
findings of this study are contrary to what is expected based on the literature reviewed
previously. The reason for this is unknown. However, the contradictory finding in this
study might be suggestive of absence of such association in relatively healthy and young
women. (Karl and others 2009)

Epidemiology of physical activity, lean body mass and iron status
Exercise can reduce fat mass. But certain levels of exercise have also been
linked to a reduction in Hb and serum ferritin. In a study by Deruisseau et al, 40 college
students were studied for iron status before and after a 12 week weight training exercise.
Iron biomarkers such as Hb, serum ferritin, serum iron, TIBC, transferrin saturation and
sTfR were examined before and after the training period. These parameters were
examined for association with percent body fat and fat free mass (FFM) or lean body
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mass. Calculation of percent body fat was based on body density formulas derived
separately for black and white populations. After weight training, the study reported
significant reduction in Hb from 13.7g/dl to 13.2 g/dl. Serum ferritin was significantly
decreased only in males with normal iron status prior to training. These levels also fell
significantly from 129.7 µg/L to 102.0 µg/L following training. For females, serum
ferritin levels did not change post-training. Other biomarkers of iron also did not change
significantly with training. Thus, weight training only had a negative effect on iron
status in males. (Deruisseau and others 2004)
McClung et al (2006) determined iron status in female military recruits (n=1216)
with three differing levels of training—1) after initial entry to the Army (IET), 2) after
basic combat training (AIT), and 3) for the duration of permanent party assignment
(PP) (McClung and others 2006). The level of iron deficiency and anemia was assessed
using a three-variable criterion including serum ferritin, transferrin saturation and red
cell distribution width (RDW). Abnormality in these variables represented iron
deficiency, whereas Hb concentration below <12g/dl was predictive of iron deficiency
anemia.
Interestingly, a significant increase in iron deficiency was observed from
baseline following basic combat training (BCT) (IET: 13.4% to AIT: 32.8%), which
was reflected in a significant increase in IDA from 5.8% to 20.9%. In agreement with
the earlier study, Hb concentration declined after basic combat training in the AIT
group. Along with Hb, serum ferritin, transferrin saturation and hematocrit decreased
significantly (p <0.001) and RDW increased post 2 weeks BCT. (McClung and others
2006)
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Although the mechanism underlying negative iron status following physical
training is unclear, one of the main reasons as stated by McClung and group was dietary
iron insufficiency during the training period based on the previous field surveys. These
surveys reported an inadequate dietary iron intake by female military personnel during
the training period. The other proposed mechanisms include external loss of iron
through sweat and urine, increased iron requirements due to expanded plasma volume
and RBCs, which might lyse and lead to net iron losses (McClung and others 2006).
Further research in this area is necessary to better understand the biological mechanism
and relationship between iron status and strenuous physical activity (Deruisseau and
others 2004; McClung and others 2006).

Summary
The prevalence of iron deficiency is highest (17.8%) among the women of child
bearing age, in industrialized nations. (WHO 2002) In this age group, maintaining
normal levels of iron is critical for the physiological functions of body. At the same
time, there is evidence that excess adiposity can adversely affect iron deficiency in
children and adults. Results can potentially vary depending on the study population,
race, dietary habits, physical activity and other lifestyle factors. Therefore we proposed
to study the association between iron status and body fat along with dietary, nutrient
intake and lifestyle factors in a population of college-aged premenopausal young
women.
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Specific aims and hypotheses
Specific aim 1
We propose to assess the relationship between serum ferritin concentrations and iron
deficiency, defined as serum ferritin < 12 µg/L, and body composition measures,
including BMI and body fat percent, and the inflammatory biomarker, hs-CRP.
Hypothesis 1
a) Serum ferritin concentrations in women aged 18-30 yrs will be positively associated
with BMI and percent body fat.
b) CRP will be positively associated with body fat and serum ferritin.
c) Body fat percent and serum hs-CRP will each be independently associated with
reduced risk of iron deficiency.
Specific aim 2
We propose to identify dietary predictors of serum ferritin in young women and to
assess the risk of suboptimal iron intake, defined as <18 mg/day (the RDA for women in
this age group) by food groups.
Hypothesis 2
a) Serum ferritin levels will be positively associated with dietary intake of iron.
b) Dietary factors known to inhibit or enhance dietary iron absorption will be either
negatively or positively associated with ferritin levels.
c) Meat, fish and poultry, followed by enriched cereals and vegetable consumption will
be associated with reduced risk of suboptimal iron intake
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Specific aim 3
We propose to describe the impact of menstrual cycle characteristics and oral
contraceptive use on serum ferritin levels and risk of iron deficiency in young women.
Hypothesis 3
Serum ferritin concentrations in young women will be positively associated with oral
contraceptive use and associated with menstrual characteristics. OC use will be
associated with reduced risk of iron deficiency.
Specific aim 4
We propose to determine the food group predictors of iron intake.
Hypothesis 4
a) Major predictors of iron intake will be meat, fish and poultry, followed by enriched
cereals and vegetables.
b) Caffeine and alcoholic beverages will be inversely associated to total iron intake
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CHAPTER 2
STUDY METHODOLOGY
Study design and population
We obtained data from the University of Massachusetts Vitamin D Status Study,
a cross-sectional study conducted at the University of Massachusetts, Amherst between
2005 and 2008 to identify factors associated with vitamin D deficiency in young
women. The eligibility criteria for the participants were: 1) 18-30 years old 2) currently
having menstrual periods 3) absence of any chronic illness, and 4) no intake of
medications known to affect vitamin D or calcium levels (eg, steroids, anticonvulsants,
beta blockers or proton pump inhibitors). Data were available for a total of 185 women.
All women provided written informed consent. The study protocol was approved by the
Institutional Review Board of the University of Massachusetts Amherst.
Anthropometric, dietary and health assessment
The participants’ clinical visits were scheduled three to five days prior to their
next estimated menstrual period. At this visit, participants were asked to complete a
semi-quantitative food frequency questionnaire (Willett and others 1985) and a second
questionnaire designed to obtain demographic data, information on general health,
lifestyle habits, and menstrual characteristics. Height, weight, and waist circumference
were measured using a stadiometer, calibrated weighing scale, and non-stretch tape
measure, respectively. Fasting blood samples were obtained by a trained phlebotomist at
the University Health Center, where whole body Dual Energy X-ray Absorptiometry
(DEXA) was also performed by a trained technician. Out of 185 eligible participants, 9
participants did not have DEXA scan. Physical activity was calculated using metabolic
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equivalents per week. (Ainsworth and others 1993) Menstrual characteristics, such as
bleeding days, length of the menstrual cycle and menstrual pattern, as well as oral
contraceptive use were obtained from the study questionnaire.
Dietary assessment
The food frequency questionnaire used for this study has been previously
described in detail (Willet and others1985). The food frequency questionnaire is a
modified version of the Harvard SFFQ containing 61 foods and has been previously
validated. (Willett and others 1985) Estimates of dietary intake of specific foods and
dietary components, such as bran and individual nutrients, were calculated from
specified portion sizes multiplied by the frequency of intake. Nutrient composition of
the specified portion size was obtained from the USDA database. For the current study,
the FFQ was used to assess food intake over the previous two months. In addition, a
write-in question was added to the questionnaire to obtain additional information on the
intake of vitamin-D fortified cereals and juices, which were not included in the original
FFQ. Nutrients that were considered for the current analyses included total iron
(mg/day), which included dietary and supplemental iron, vitamin A (RAE/day), vitamin
C (mg/day), calcium (mg/day), copper (mg/day), magnesium (mg/day), zinc (mg/day),
caffeine (mg/day), alcohol (g/day) and total dietary fiber (g/day). Food groups such as
cereals, legumes, vegetables, fruits, dairy, eggs, meat, fish and poultry, coffee and tea,
and alcoholic beverages were also included to assess their contribution to iron intake
and their potential association with iron status, measured as serum ferritin
concentration.)
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Body composition measures
Whole body DEXA scans were performed using the GE Lunar Prodigy Scanner
(GE Lunar Corp., Madison, WI). The scans were performed with the participant lying in
a supine position. The DEXA scanner was calibrated with a phantom as per the
manufacturer’s instructions. The DEXA scans were used to calculate body fat and lean
body mass as measures of body composition. Body mass index (BMI) was calculated as
kg/m2 based on the participants’ recorded body weight and height.
Laboratory analyses
Fasting venous blood samples obtained from the participants were kept on ice
for one to two hours before being centrifuged to obtain serum, which was aliquoted and
frozen at -80° C until subsequent biomarker assessment. Serum ferritin concentrations
were determined as a measure of iron status using a commercially available enzyme
immunoassay (EIA) kit (RAMCO Laboratories, TX). In brief, duplicate 10-µL serum
samples and purified alkaline phosphatase-conjugated antihuman ferritin antibody were
pipetted into 96-well microplates coated with solid phase antihuman ferritin antibody.
After 2 hrs of incubation with shaking at 180 rpm at room temperature, the plates were
washed three times with deionized water. Substrate solution was added and allowed to
stand for 30 minutes. Potassium ferricyanide was then added to develop a color. The
absorbance was read at 490 nm and a background correction wavelength of 630 nm
using a 96-well plate reader (Dynex Revelation , Dynex Technologies, Chantilly, VA).
Absorbance values were entered into the Spectro Ferritin MT- calculation program
provided by RAMCO laboratories for calculation of ferritin concentrations.
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High sensitivity C- reactive protein (hs-CRP) was assessed by a latex-enhanced
turbidimetric immunoassay kit (Equal Diagnostics, Exton, PA) using an automated
analyzer and a high sensitivity calibration curve. The high sensitivity method allows
detection of CRP in the range of 0.05 mg/L to 80.0 mg/L. CRP levels exceeding the
higher level were diluted and retested using a multiplication by dilution factor.

Statistical Analysis
Statistical analyses were conducted using SPSS Windows version 16.0 (SPSS
Inc. Chicago, IL). Descriptive statistics (mean, SD) were used to characterize the
population in terms of continuous variables, such as age, BMI (kg/m2), percent body fat,
percent lean mass, waist circumference (inches), physical activity (METs/week), and
serum concentrations of hs-CRP (mg/L) and ferritin (µg/L). Descriptive methods were
also used to characterize dietary intakes of food groups (as cereals, lentils, vegetables,
fruits, dairy, eggs, meat, fish and poultry, coffee and tea and alcoholic beverages) and
nutrients [total iron (mg/day), dietary iron, supplemental iron, vitamin A (RAE/day),
vitamin C (mg/day), calcium (mg/day), copper (mg/day), magnesium (mg/day), zinc
(mg/day), caffeine (mg/day), alcohol (g/day) and total dietary fiber (g/day)].
Categorical variables such as race, oral contraceptive use, smoking status,
menstrual characteristics are presented as N and percentages. Iron deficiency was
defined as serum ferritin <12 µg/L. For the categorical analysis of covariates, the
variables such as percent body fat (< 24, 24- 32, >32), BMI (<25, >25) and CRP (<3, >3
mg/L) were classified using standard cut off values. The nutrient intake covariates were
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dichotomized using age- and gender-appropriate RDA cut-off levels for respective
nutrients.
The Kurtosis test revealed that neither outcome variable (iron intake or serum
ferritin) was normally distributed, so we improved the normality of the distributions by
transforming serum ferritin to its square root, and by obtaining the natural log of iron
intake. These transformed values were used in tests (linear regression) that assume a
normal distribution of the outcome variable.
Significant differences in median ferritin concentrations by covariate categories
were identified using non-parametric tests, including the Wilcoxon Rank Sum Test (two
medians) and the Kruskal Wallis Test (three or more medians). Analysis of
dichotomized serum ferritin by covariates was performed using Wilcoxon Rank Sum
Test for continuous covariates and chi-square analysis for categorical covariates.
Correlation analysis was performed using Pearson’s correlation coefficient, with square
root transformed serum ferritin as a dependent variable.
Separate univariable linear regression analyses were carried out to identify
possible predictors of total iron intake (natural log) and serum ferritin (square root). All
covariates that had a p value of <0.25 in univariable models were included in the initial
multivariable model. Body composition measures, such as BMI and body fat percent,
were strongly correlated with one another (r= 0.73; p= 0.00), so they were not included
in the same models to avoid issues regarding collinearity between the independent
variables.
After this first step of multivariable analysis, we excluded the covariates with a p
value >0.15. The final multivariable linear regression model for the predictors of iron
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intake included all of the food groups; supplemental iron and total energy intake were
also included in the final model. The final multivariable linear regression model for
serum ferritin predictors included age, hs-CRP, body fat percent, iron intake, oral
contraceptive use, bleeding days and total energy intake. The data are presented as R2,
beta coefficient, 95% confidence intervals and p value.
Univariable logistic regression was performed with dichotomized serum ferritin
(< 12 µg/L) and iron intake (< 18 mg/day) to assess the risk of iron depletion and low
dietary iron intake, respectively. The final multivariable logistic regression model for
iron depletion included age, hs-CRP, iron intake, body fat percent, bleeding days and
oral contraceptive use. The final multivariable logistic regression model for low iron
intake included all the food groups (cereals, lentils, vegetables, fruits, dairy, eggs, meat,
fish and poultry, coffee and tea and alcoholic beverages), and supplemental iron. The
results of logistic regression were presented as odds ratio, 95% confidence intervals and
p value. For all analyses, statistical significance was set at p<0.05.
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CHAPTER 3
RESULTS
Our study included 185 18- to 30-year old women from Amherst, Massachusetts.
The demographic characteristics of the population as well as dietary and other factors
thought to influence ferritin status are presented in Table 1. The population was mostly
young and predominantly white, with a few Asians and African Americans. Most
women had a BMI within the normal range, although percent body fat was greater than
32 in nearly half of the women.
Serum ferritin (SF) concentration ranged from 1.4 to 114.3 µg/L. Overall, 28% of
women had serum ferritin concentrations <12 µg/L. The mean concentration of high
sensitivity C-reactive protein (hs-CRP mg/L) was 3.0 (5.9), with 70% of the population
below the cut off level (< 3mg/L) associated with increased cardiovascular disease risk
(Mainous and others 2004). Percent body fat and hs-CRP were significantly correlated.
(r=0.3; p=0.00)
Oral contraceptives (OCs) were currently being used by nearly 40% of women.
Only about 6% of women reported that their menstrual pattern was irregular. Nearly
two-thirds of women reported a cycle length of 26 to31 days, and 70% reported four to
five bleeding days per cycle. Physical activity in reference to energy expenditure at rest
was measured as metabolic equivalents tasks per week classified by intensity of activity
(METs). The mean score in this population was 58.6 (54.9). Although mean intakes of
nutrients were above the RDA for women in this age group, the range of intakes
indicates that many women were not achieving RDA levels (Table 2).

41

Because serum ferritin concentration was not normally distributed, we used
nonparametric methods to compare serum ferritin medians across the categories of
covariates (Table 3). Median serum ferritin was significantly higher in women over 21
years of age (the median) than in younger women. Median ferritin was also significantly
higher among women with hs-CRP levels greater than 3 mg/L than in those with lower
hs-CRP concentrations. Although serum ferritin was significantly lower among current
OC users (24.8 ± 22.8) than in nonusers (28.3 ± 20.5; p =0.04), no other significant
differences in median ferritin were observed across categories of menstrual
characteristics. Median ferritin levels did not differ across categories of nutrients (≥
RDA vs. < RDA; data not shown).
We conducted univariable linear regression analyses to evaluate the associations
between potential covariates and (square root) serum ferritin (Table 4). Age and hs-CRP
were significantly and positively associated with serum ferritin. None of the body
composition parameters (BMI, percent body fat) was associated with serum ferritin, but
the number of bleeding days was strongly inversely associated with serum ferritin.
Although consumption of nutrients such as vitamin A and copper were strongly
associated with serum ferritin (p ≤ 0.05), total iron intake and iron intake from food
only were not (p > 0.05)
In multivariable linear regression analyses, age, hs-CRP, OC use and number of
bleeding days remained significantly associated with serum ferritin (Table 5). Dietary
nutrients that were significantly associated with serum ferritin in univariable analyses
were no longer significant in the multivariable models. Consistent with the univariable
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analysis, body fat percent was not associated with serum ferritin while controlling for
other factors (Table 6).
We also used linear regression analyses to identify the dietary predictors of iron
intake (logarithmically transformed). In univariable analyses (Table 7), cereals, legumes,
vegetables and fruits were significantly associated (p <0.01) with total iron intake,
although meat intake was not. Supplemental iron intake was also a strong, significant
predictor of total iron intake (R2 =0.42; p = 0.00). In a multivariable model that was not
adjusted for meat intake, (Table 8), cereals, legumes, vegetables, fruits, eggs,
supplemental iron (p<0.01) and dairy (p<0.05) remained significant predictors of iron
intake, and the coefficient estimates remained similar after removing nuts, coffee and
tea from the model (Table 9). However, when meat intake was forced into this model
(Table 10), it became a strong predictor (p <0.01) of total iron intake, along with
cereals, legumes, vegetables, fruits, and supplemental iron.
We used univariable logistic regression analyses to identify factors associated with
risk of iron deficiency, which we defined as serum ferritin <12 µg/L (Table 11). Each
one-year increase in age was associated with a 15% decrease in the risk of iron
deficiency Compared to current OC use, the risk of iron deficiency was 53% lower in
non OC users. No other covariates were significantly associated with iron deficiency in
univariable analyses.
Categories of percent body fat, hs-CRP categories, and other factors in the
univariable model that were significant at the p < 0.25 level were included in a
multivariable logistic regression model (Table 12). The significant predictors in the
univariable models remained significant in the multivariable analysis. While the odds
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ratio for most covariates were virtually unchanged, the protective effect associated with
non-use of contraceptives was more pronounced when controlling for other factors
(OR= 0.29; 95% CI 0.12-0.67). In addition, compared to those who reported three or
fewer menstrual bleeding days, the risk of iron deficiency was more than six-times
greater among women in the highest category of bleeding days (6-7 days; OR = 6.2;
95% CI 1.3-29.3).
We also used univariable logistic regression to identify dietary factors associated
with risk of suboptimal iron intake, which we defined as < 18 mg per day, the RDA for
women in this age group (Table 13). Dietary intake of cereals, vegetables, fruits,
legumes and supplemental iron were all protective against suboptimal iron intake,
although intake of meat was not significantly associated with risk of suboptimal intake.
The multivariable logistic model of suboptimal iron intake (Table 14) included all
covariates with a p value < 0.25 in the univariable models. Increased intake of cereals,
legumes and supplemental iron remained protective against inadequate iron intake in the
multivariable model. While fruit and vegetable intake tended to be protective, their
effect was no longer statistically significant in the multivariable model. Meat intake was
also significantly protective against inadequate iron intake after controlling for other
dietary factors and supplemental iron intake. Alcohol intake was associated with a near
doubling of the risk of inadequate iron intake, but this effect did not reach statistical
significance.
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CHAPTER 4
DISCUSSION
Iron status is of special concern in women of child-bearing age because it
influences not only the woman’s health, but also that of her infant if she becomes
pregnant. Our study focused on young, apparently healthy premenopausal women. We
found no association between serum ferritin concentration and measures of body
composition, including BMI and percent body fat.
Our results are in contrast to those of several earlier studies, which reported
associations between adiposity and various markers of iron status, with the direction of
the association depending on the iron biomarker (e.g., inverse for serum iron, positive
for serum ferritin) (Chambers and others 2006; Iwasaki and others 2005; Yanoff and
others 2007) However, the study populations in previous reports generally differed from
ours in terms of age, sex and race, and these factors can influence not only iron status,
but also body composition (Chambers and others 2006; Yanoff and others 2007;
Iwasaki and others 2005) For instance, in the study by Chambers et al (2006) and
Iwasaki et al (2005), the subjects included postmenopausal women, and the mean age of
the study participants was over 50 years (Chambers,E.C. 2006; Iwasaki,T. 2005)
Although the study by Yanoff et al (2007) included subjects within our range of 18 to
30 years, the mean age of their cohort (38 years) was substantially higher than the
average age of women in our study (21.5 years). We also observed a positive
association between serum ferritin concentration and age. This association has been
reported previously by Gillum et al.(2001), using data from NHANES. They found that
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increased age was positively associated with serum ferritin, especially in the third
decade of life.(Gillum 2001) Although the mechanism for an age-associated change in
ferritin level is not yet clear, it is possible that the differences in mean age among
studies could potentially influence the relationship between serum ferritin and adiposity,
particularly since adiposity has also been reported to increase with age. (Gillum 2001)
In addition to differences in age, the mean BMI and percent body fat in previous
studies were also much greater than in our study. For instance, in the study by Yanoff et
al. (2007), the mean BMI of the “nonobese” group was 25.6 kg/m2, compared to 22.8
kg/m2in our study. The fact that Yanoff et al. (2007) reported an association between
obesity and serum ferritin concentration, suggests that the degree of adiposity might
play a major role in predicting body iron status. In other words, an association might be
observed in women with a higher percent body fat but not in those in the normal range
of adiposity.
Race may also influence the relationship between ferritin and body composition.
For instance, although the NHANES study (Gillum et al, 2001) reported a significant
relationship between serum ferritin and body fat measurements, the analysis was limited
to Mexican American males, and it is possible that the relationship is different in a
group of women who are predominantly Caucasian.
The results of our study are consistent with the very recent findings of Karl et al
(2009), in which high body fat percent (> 30% via skinfolds) and BMI (25-30 kg/m2)
were not associated with iron deficiency (defined as two or more of the following blood
indicators: red cell distribution width > 15.0%, transferrin saturation < 16.0%, serum
ferritin < 12.0 ng/mL) in premenopausal women, ranging in age from 18 to 41 years.
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These authors speculate that a “critical level of fat mass” may be needed to induce the
inflammatory condition that leads to altered iron status. (Karl and others 2009)
We found a positive association between hs-CRP and serum ferritin, which has
been well- documented in previous studies. (Mainous and others 2004; Yanoff and
others 2007) CRP is a hepatic protein that is released in response to inflammation.
Although ferritin serves primarily as a storage form of iron, it is also a positive acutephase reactant that, like CRP, rises in response to inflammatory signals, including
adipokines released by adipocytes. (Jehn, Clark, Guallar 2004; Weiss and Goodnough
2005; Yanoff and others 2007) In our study, we found that hs-CRP was positively
associated percent body fat and BMI (r=0.28 and 0.19, respectively).
Based on the study by Yanoff et al (2007), one can postulate that higher body fat
may result increased iron stores in the form of serum ferritin. This can be explained by
the physiological association of the inflammatory response to fat accretion. In our study,
hs-CRP was significantly correlated with serum ferritin as well as body fat measures.
This indicates that the inflammatory cytokines are triggered in response to increased
body fat. Consequently, as a defense mechanism, hepcidin is released. Hepcidin is an
iron regulatory protein that inhibits the release of iron from macrophages and
enterocytes, thus causing increased serum ferritin and decreased circulatory iron.
(Nemeth and others 2004c) The inflammatory response can also be explained by
increase in ferritin synthesis as an acute phase response, resulting into decreased
absorption of iron by the small intestine. (Weiss and Goodnough 2005) The hepcidin
mechanism was elucidated in a study where, hepcidin expression was observed in
hepatocyes as well as adipocytes of severely obese subjects. Hepcidin expression was

47

positively correlated with inflammatory biomarkers such as CRP (Bekri and others
2006; Yanoff and others 2007). This can possibly explain the contradictory findings in
our study.
We found that mean serum ferritin was significantly higher in non-users of OCs
than in current users. In addition, we found that the risk of iron deficiency was also 53%
lower in nonusers than in those currently using OCs. The influence of OC use on iron
status has been studied extensively, with conflicting findings. Earlier studies
(Frassinelli-Gunderson, Margen, Brown 1985; Milman, Sondergaard, Sorensen 1985)
reported an improvement in iron status after the use of OCs for six months. However,
other studies have shown that the use of low-dose or third generation OCs does not alter
iron status significantly (Casabellata and others 2007; Larsson and others 1992),
possibly due to the fact that the low hormonal dose in current OCs reduces menstrual
blood loss to a lesser extent than did earlier contraceptive pills. It is also possible that
women in our study were prescribed OCs due to iron-deficiency anemia, which could
explain the lower concentration of ferritin observed in OC users if the women had not
yet had time to become iron replete. Future studies will need to assess other factors
related to OC use, such as the reason for their initiation and the duration of use.
Among the menstrual characteristics, the number of reported bleeding days was
significantly associated with ferritin concentration. This observation is supported by
many studies, which clearly demonstrate the inverse association between number of
bleeding days as well as the intensity of menstrual loss and iron status indicators.
(Fogelholm and others 1993; Milman, Sondergaard, Sorensen 1985) These results are
also consistent with a recent study in Japanese young women, which found that
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increased bleeding days and extreme menstrual losses were strong predictors of iron
deficiency. (Asakura and others 2009)
With respect to nutrient intake, we found that total iron intake (dietary iron plus
supplemental iron) was not a significant predictor of ferritin concentration in either
univariable or multivariable linear regression analyses. In addition, iron intake was not a
significant risk factor for iron deficiency (ferritin < 12 µg/L). This finding is similar to
that reported by Pynaert et al (2007), who also concluded that iron intake did not
influence iron status parameters in young adult women. Although intake of other
nutrients, including vitamin A and copper, was significantly associated with serum
ferritin in univariable regression models, these nutrients were no longer significant in
multivariable models. Our findings are in agreement with those of Asakura et al (2009),
who studied1019 young Japanese women (18-25 years). Their study of 16 nutrients
concluded that none of the dietary components was significantly associated with iron
deficiency (serum ferritin <12 µg/L). .
We further explored the contribution of various food groups to dietary iron intake.
In univariable models (Table 7), nonheme iron sources such as cereals, vegetables,
lentils and fruit were positively associated with total iron intake, although heme iron
sources (“meat,” which included meat, fish and poultry) were not. However, when
supplemental iron was included in multivariable models, meat intake also became
significantly associated with total iron intake.
The contribution of cereals to total iron intake can be explained by the fact that
many cereal products are either iron-fortified or made with iron-enriched flour, and
these types of foods are often a large proportion of the total diet. The positive
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association between cereal intake and total dietary iron was also reported in Belgian
study by Pynaert et al (2007). They found that cereals and vegetables (31% and 10%,
respectively) were significant predictors of total iron intake and that meat intake (12%)
was also a significant contributor to iron intake.

Strengths and limitations
One important strength of the current study is that our population of young women
was healthy and relatively homogeneous in terms of race and education level, which
reduced between-person variation and improved our ability to detect associations among
our exposure and outcome measures. Moreover, the relationship between iron status and
body fat has rarely been studied in young and predominantly non-obese women, and our
study group was relatively lean. Another important strength was our use of DEXA
measurements to assess adiposity in addition to conventional methods of body fat
assessment, such as BMI and waist circumference. Because DEXA is considered a
more accurate and reliable method of determining body composition, our use of this
technology strengthened our assessment of adiposity.
Iron status in young women depends on several important contributing factors,
including dietary intake of iron and other nutrients, menstrual characteristics, oral
contraceptive use and physical activity. Our ability to measure these factors in the
current study made our study more comprehensive than previous studies and
strengthened our ability to reduce random error.
One limitation of our study was that it relied solely on serum ferritin as the only
biomarker of iron status. Because serum ferritin increases in response to inflammation,
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normal or elevated levels may be falsely interpreted as iron sufficiency if the subject is
in an inflammatory state. Although inflammation is generally associated with infection
or tissue damage, increased adiposity is also a pro-inflammatory state, and we did
observe a positive association between hs-CRP levels and measures of adiposity (r=0.3;
p=0.00). Although we can be confident that women with serum ferritin <12 µg/L were
in fact iron deficient (28% of our study group), we cannot be certain that women with
ferritin concentrations >12 µg/L were necessarily iron replete, particularly if their hsCRP levels were elevated. However, we found that only 13 of the women in our study
had hs-CRP levels > 8 mg/L, indicative of a substantial acute-phase response. Of those,
just three had borderline ferritin levels (12.5 to 31 µg/L) that would suggest that the
women may have been misclassified as iron replete. Other measures of iron status, such
as serum iron or serum transferrin receptor, may have provided a broader understanding
of the relationship between iron status, inflammation and body fat.
Although also a strength, another potential limitation of our study was the fact that
our cohort consisted of young, predominantly Caucasian women who were generally
within the normal range of BMI. Although measures of percent body fat suggested that
45% of women were somewhat overfat (>32%), they did not appear to be extremely so,
and it is possible that the level of adiposity that we observed was not sufficient to
promote an inflammatory response. Although hs-CRP was associated with adiposity, we
found no difference in mean serum ferritin concentrations across percent body fat
categories. Additional studies are needed to confirm these findings in older and more
ethnically diverse populations that have a wider distribution of BMI and percent body
fat measurements.
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Conclusion
This study demonstrated that body composition was not associated with ferritin
status or the risk of iron deficiency in a group of young premenopausal women.
Although inflammation plays a key role in predicting iron status, as evidenced by the
association between hs-CRP and ferritin concentration or risk of iron deficiency, and hsCRP was associated with percent body fat, we did not find a significant association
between adiposity and ferritin status. We also found that, despite the greater efficiency
of heme iron absorption, dietary components—including meat intake--did not
significantly predict serum ferritin levels. Additional studies are needed to further
explore the dietary and lifestyle factors that influence iron status in young women.
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TABLES
Table 1: Characteristics of study population
(N= 185)

Age

N
185

Height (cm)

185

149.9-182.9

166.4 (6.0)

Weight (kg)

185

40.6-87.5

63.4

(9.8)

BMI (kg/m2 )
< 25
≥ 25

185
142
43

16.8- 33.0

22.8

(3.1)

76.8
23.2

Body Fat %
<32
>32

176
92
84

14.5- 50.1

31.9

(7.9)

49.7
45.4

Waist Circumference (in)

185

24.0- 45.0

30.9

(3.4)

Physical Activity (METs) *

185

0-374.2

58.6 (54.9)

Race
White
Black African American
Asian
Other

185
158
4
13
10

Serum Ferritin (mcg/L)
<12 mcg/L
>12 mcg/L

181
51
134

1.4- 114.3

26.9

(21.4)

Hs-CRP (mg/L)
<3
>3

179
130
49

0.1- 42.8

3.0

(5.9)

70.3
26.5

Current Oral Contraceptive Use
Yes
No

185
73
112

39.5
60.5

53

%

(Continues on the next page)
Range
Mean (SD)
18.0 – 31.0
21.5 (3.2)

85.4
2.2
7.0
5.4

27.6
72.4

Current Smoking Status
Yes
No

185
9
176

4.9
95.1

Menstrual Characteristics
Menstrual Pattern
Extremely regular
Very regular
Regular
Usually irregular
Always irregular

185
70
53
52
7
3

37.8
28.6
28.1
3.8
1.6

Length of period (days)
<21
21-25
26-31
32-39
40-50
>51

185
2
39
116
21
1
6

1.1
21.1
62.7
11.4
0.5
3.2

Bleeding days
<3
4-5
6-7

185
28
129
28

15.1
69.7
15.1

* Metabolic equivalents per week
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Table 2: Distribution of food group and nutrient intakes in study population
(N= 185)
Variable

Range

Mean (SD)

Food group intake
(servings/day)
Cereal
Legumes
Vegetables
Fruits
Dairy
Eggs
Meat*
Coffee and tea
Alcoholic beverages

0.4- 14.1
0.0- 4.5
0.2- 22.8
0.0- 10.1
0.0- 10.9
0.0- 6.0
0.0- 5.6
0.0- 9.0
0.0- 5.0

3.4 (2.1)
0.3 (5.4)
5.0 (3.4)
2.6 (1.8)
2.6 (1.8)
0.4 (0.6)
1.2 (1.0)
1.1 (1.3)
0.4 (0.6)

Nutrient Intakes (per day)
Iron (mg)
Total
Food only
Supplemental
Vitamin C (mg)
Carotenoids (RAE)
Retinol (RAE)
Vitamin A (RAE)
Copper (mg)
Calcium (mg)
Magnesium (mg)
Zinc (mg)
Caffeine (mg)
Bran (g)
Fiber (g)**
Alcohol (g)

4 – 101
4 – 73
0.0- 87
16- 1626
75-15074
12 -4521
357 -16886
0.3- 6
129 – 3553
79- 1057
3 – 72
0.0- 880
0.1- 35
6 – 120
0.0- 70

25
19
6
208
4410
802
5172
2
1151
419
18
95
6
30
6

*
**

Includes meat, fish and poultry
Total fiber intake per day
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(16)
(10)
(13)
(180)
(2978)
(653)
(3004)
(0.9)
(506)
(177)
(10)
(109)
(5)
(18)
(8)

Table 3: Distribution of median serum ferritin (µg/L) by covariate categories
(Cotinues on the next page)
Covariates
N
%
Median (range)
P value*
Age
≤ 21 yrs
> 21 yrs

185
111
74

59.7
40.3

19.4 (1.4-97.2)
26.6 (2.6-114.6)

0.01

Race
White
Black African American
Asian
Other

158
4
13
10

85.4
2.2
7.0
5.4

21.5
26.0
36.8
22.1

(1.4-97.2)
(4.9-51.5)
(5.8-114.3)
(8.0-87.5)

0.16

BMI (kg/m2)
< 25
≥ 25

142
43

76.8
23.2

21.1 (1.4-97.2)
24.4 (2.6-114.3)

0.43

Body Fat %
≤ 24
24-32
> 32

40
61
84

21.6
33.0
45.4

20.1 (3.2-114.0)
23.2 (1.9-80.2)
22.3 (1.4-114.3)

0.90

Hs-CRP (mg/L)
≤3
>3

130
49

70.3
26.5

20.3 (1.4-114.0)
24.1 (3.4-114.3)

0.04

Current Oral Contraceptive Use
Yes
No

72
112

39.5
60.5

17.3 (2.4-114.0)
24.7 (1.4-114.3)

0.04

Current Smoking Status
Yes
No

9
176

4.9
95.1

33.6 (7.6-69.9)
21.1 (1.4-114.3)

0.11

70
53
52
7
3

37.8
28.6
28.1
3.8
1.6

18.8 (3.8-114.0)
27.5 (1.4-114.3)
18.1 (1.9-56.8)
26.8 (8.8-30.3)
23.9 (8.0-40.7)

0.15

Menstrual Characteristics
Menstrual Pattern
Extremely regular
Very regular
Regular
Usually irregular
Always irregular
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Length of period (days)
<21
21-25
26-31
32-39
40-50
>51

2
39
116
21
1
6

1.1
21.1
62.7
11.4
0.5
3.2

46.6 (44.2-48.9)
25.3 (2.4-94.5)
20.6 (1.9-114.3)
17.3 (1.4-86.9)
40.7 (40.7-40.7)
23.9 (7.8-70.1)

0.19

Bleeding days
<3
4-5
6-7

28
129
28

15.1
69.7
15.1

25.3 (2.6-97.2)
22.0 (1.9-114.3)
19.1 (1.4-60.5)

0.11

* Wilcoxon Rank Sum Test and Kruskal Wallis Test, as appropriate, for the comparison of two or three
plus groups, respectively
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Table 4: Univariable regression analysis of serum ferritin (sq root) by covariates
Predictor

Beta

R2

P value*

Age (yrs)

0.15

0.06

0.001

Race

0.22

0.02

0.06

BMI (kg/m2 )

0.03

0.00

0.53

Waist Circumference (inches)

0.01

0.00

0.77

Body Fat %

0.002

0.00

0.89

Hs-CRP

0.09

0.08

0.00

Physical Activity (METs)**

-0.001

0.00

0.57

Current Oral Contraceptive use

0.45

0.01

0.12

Current smoking status

-0.79

0.01

0.23

Menstrual Characteristics
Menstrual Pattern
Length of period
Bleeding days

-0.15
-0.08
-0.59

0.01
0.00
0.03

0.29
0.65
0.02

Nutrient Intake (per day)
Iron (mg)
Total
Food Only
Vitamin C (mg)
Vitamin A (mcg RAE)
Copper (mg)
Calcium (mg)
Magnesium (mg)
Zinc (mg)
Caffeine (mg)
Fiber (g)
Alcohol (g)

0.01
0.009
0.001
0.00
0.30
0.00
0.001
0.02
0.00
0.01
0.00

0.02
0.00
0.02
0.03
0.02
0.00
0.01
0.01
0.00
0.01
0.00

0.10
0.52
0.10
0.03
0.05
0.98
0.13
0.17
0.91
0.17
0.97

*

Covariates with p-value <0.25 were included in a multivariable regression model
** Metabolic Equivalents per week
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Table 5: Multivariable regression analysis of serum ferritin by covariates *
Predictor§

Beta

P value§

Age (yrs)

0.13

0.002

hs- CRP (mg/L)

0.09

0.00

Oral contraceptive use

0.76

0.01

Bleeding days

-0.55

0.03

Model :
R2 = 0.186

*

Model not adjusted for body fat percent
Covariates that had p-value of < 0.25 (race, iron intake, vitamin C, vitamin A, copper, magnesium, zinc,
fiber) were not significant in the intermediate multivariable model, thus removed in the final model

§

Table 6: Multivariable linear regression analysis of serum ferritin by covariates **
Predictor

Beta

P value

Age (yrs)

0.13

0.004

hs- CRP (mg/L)

0.10

0.00

Body fat %

-0.01

0.49

Oral contraceptive use

0.78

0.01

Bleeding days

-0.55

0.03

Model :
R2 = 0.188

** Model adjusted for body fat percent
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Table 7: Univariable regression analysis of iron intake* by food groups
Beta

R2

P value**

Cereals

0.05

0.19

0.00

Legumes

0.15

0.10

0.00

Meat §

0.02

0.01

0.31

Eggs

0.03

0.01

0.23

Dairy

0.02

0.02

0.06

Vegetables

0.03

0.15

0.00

Fruits

0.04

0.07

0.00

Nuts

0.07

0.02

0.07

Coffee & tea

0.02

0.01

0.15

Alcohol

-0.02

0.00

0.49

Supplemental iron

0.01

0.42

0.00

Predictor
Food group
(Servings/day)

* Log transformed iron intake
** Covariates with p value < 0.25 were included in a multivariable model
§
Includes meat, fish and poltry
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Table 8: Multivariable regression analysis of iron intake* by food groups
Predictor

Beta

P value

Cereal

0.05

0.00

Legumes

0.05

0.01

Eggs

0.04

0.01

Dairy

0.01

0.03

Vegetables

0.01

0.00

Fruits

0.02

0.01

Nuts

0.02

0.38

Coffee and tea

0.01

0.52

Supplemental iron

0.01

0.00

Model : R2 = 0.77
Food groups (servings/day)

*Log transformed iron intake
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Table 9: Multivariable regression analysis of iron intake by food groups*
Predictor**

Beta

P value

Cereal

0.05

0.00

Legumes

0.06

0.01

Dairy

0.01

0.03

Vegetables

0.01

0.00

Fruits

0.02

0.01

Eggs

0.04

0.01

Supplemental iron

0.01

0.00

Model : R2 = 0.79
Food groups (servings/day)

* Unadjusted for meat intake per day
** Excludes nuts, meat, coffee and tea, alcoholic beverages
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Table 10: Multivariable regression analysis of iron intake by food groups*
Predictor

Beta

P value

Cereal

0.05

0.00

Legumes

0.06

0.002

Dairy

0.01

0.06

Vegetables

0.01

0.00

Fruits

0.02

0.003

Eggs

0.02

0.09

Meat

0.04

0.001

Supplemental iron

0.01

0.00

Model : R2 = 0.77
Food groups (servings/day)

* Adjusted for meat intake per day
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Table 11: Unadjusted univariable odds ratio for iron deficiency* by covariates
Odds Ratio

95% CI

P value

Age (yrs)

0.85

0.75- 0.98

0.02

hs- CRP (mg/L)

0.96

0.90- 1.04

0.33

Body fat %

0.99

0.95- 1.04

0.81

Iron intake (mg/day)

0.99

0.96- 1.01

0.21

Physical activity (METs/wk)

1.00

0.99- 1.01

0.87

Oral contraceptive use
Yes
No

1.00
0.47

ref
0.24- 0.90

0.02

Bleeding Days
<3
4-5
6-7

1.00
2.41
3.33

ref
0.78- 7.43
0.90- 12.36

0.16
0.07

Categorized variables:
hs- CRP
< 3 mg/L
> 3 mg/L

1.00
0.64

Ref
0.29- 1.42

0.28

1.00
0.71

Ref
0.37- 1.40

0.33

Body Fat %
<32
>32

*Iron deficiency defined as serum ferritin < 12mcg/L
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Table 12: Adjusted odds ratio for iron deficiency* by covariates

Age (yrs)

Odds Ratio
0.84

95% CI
0.72- 0.99

P value
0.04

hs- CRP (mg/L)
< 3 mg/L
> 3 mg/L

1.00
0.50

ref
0.2- 1.4

0.17

Body fat %
<32
>32

1.00
0.85

ref
0.4- 1.4

0.69

Iron intake (mg/day)

0.99

0.96- 1.02

0.37

Oral contraceptive use
Yes
No

1.00
0.29

Ref
0.12- 0.67

0.004

Bleeding Days
<3
4-5
6-7

1.00
2.54
6.24

Ref
0.7 - 9.3
1.3 – 29.3

0.16
0.02

*Iron deficiency defined as serum ferritin < 12mcg/L
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Table 13: Unadjusted univariable odds ratio for suboptimal iron intake* by food
groups

Cereal

Odds ratio
0.54

95% CI
0.42- 69

P value
0.00

Vegetables

0.78

0.68- 0.89

0.00

Fruits

0.76

0.62- 0.93

0.007

Legumes

0.07

0.02- 0.25

0.00

Dairy

0.91

0.76- 1.08

0.27

Eggs

0.78

0.47- 1.29

0.33

Meat

0.83

0.61- 1.13

0.24

Coffee and Tea

0.88

0.70- 1.11

0.27

Alcohol

1.45

0.87- 2.40

0.15

Supplemental iron

0.75

0.64- 0.87

0.00

* Suboptimal iron intake based on RDA cut off value of <18mg per day
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Table 14: Adjusted odds ratio for suboptimal iron intake* by food groups§
Odds Ratio

95% CI

P value

Cereal

0.32

0.2 - 0.5

0.00

Vegetables

0.81

0.6 - 1.02

0.08

Fruits

0.72

0.5 - 1.02

0.07

Legumes

0.07

0.01- 0.5

0.006

Meat

0.25

0.1- 0.5

0.00

Supplemental iron

0.57

0.4 - 0.8

0.00

Alcoholic beverages

1.83

0.9 – 3.9

0.12

* Suboptimal iron intake based on RDA cut off value of <18mg per day
§

Excluded variables: eggs, dairy, coffee and tea
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